N.Y. Comp. Codes R. & Regs. tit. 9, § 114.9 – Packaging and labeling of cannabinoid hemp products.

(a) All cannabinoid hemp products distributed or offered for retail sale in New York State shall include the following information on the product label or packaging:
1. (1) if the cannabinoid hemp product is consumed through ingestion, including sublingual or oral absorption, comply with the requirements in Title 21 Code of Federal Regulations Part 101 and include a nutritional or supplement fact panel that is based on the number of servings within the container;
2. (2) a list of all ingredients in descending order of predominance by weight in the product;
3. (3) the number of servings per outer package or container, including the milligrams per serving and the milligrams per package of:
  1. (i) CBD;
  2. (ii) “Total THC” or “THC” which for the purposes of product labeling shall include detectable levels of total Δ9-Tetrahydrocannabinol, Δ8-Tetrahydrocannabinol and Δ10-Tetrahydrocannabinol; and
  3. (iii) any other marketed cannabinoid;
4. (4) an expiration or best by date if applicable;
5. (5) a lot or batch number;
6. (6) the name of the cannabinoid hemp processor or out of state manufacturer, packer or distributor;
7. (7) a scannable bar code or QR code linked to a downloadable certificate of analysis, or linked to a website where the certificate of analysis can be downloaded;
8. (8) the country or (countries) of origin from which hemp used in the product was sourced;
9. (9) a means for reporting serious adverse events or side effects; and
10. (10) any other marking, statement or symbol as required by the office in regulation.
(b) No cannabinoid hemp product packaging shall imitate a candy label or use cartoons or other images popularly used to advertise to children or otherwise be marketed to anyone under 18 years of age, or for inhalable cannabinoid hemp products and flower product, to anyone under 21 years of age.
(c) All cannabinoid hemp products shall be packaged in tamper-evident packaging that minimizes oxygen and light exposure to prevent degradation of the product and cannabinoids.
(d) All cannabinoid hemp products shall be accompanied by recommended serving and clear usage instructions.
(e) All cannabinoid hemp products claiming to be isolate, full spectrum, broad spectrum, or distillate shall comply with the applicable definition contained in this Part.
(f) All cannabinoid hemp products offered for retail sale shall include the following warnings on the product label or packaging, in a manner that is clear and conspicuous:
1. (1) keep out of the reach of children;
2. (2) that the product is derived from hemp and may contain THC which could result in a failed drug test. Provided however, this warning may be omitted for cannabinoid hemp products that are: topically applied; made exclusively using an “isolate;” or made from “broad spectrum” hemp extract derived entirely from hemp grown, extracted, and manufactured in New York State;
3. (3) that the product has not been evaluated by the Food and Drug Administration for safety or efficacy;
4. (4) those who are pregnant or nursing should consult their healthcare provider before use; and
5. (5) if the product is an inhalable cannabinoid hemp product, a warning stating that smoking or vaporizing is hazardous to your health.
(g) No information required to be listed on cannabinoid hemp product labeling or packaging in accordance with this section shall be smaller than 4.5-point font, and the information required by subparagraphs (a)(3)(i) through (iii) and paragraph (f)(2) of this section shall be bolded and at least one font sized larger than other text required to be listed on the product label.